During the last session, Q32 Bio Inc (NASDAQ:QTTB)’s traded shares were 0.74 million, with the beta value of the company hitting -0.31. At the end of the trading day, the stock’s price was $3.91, reflecting an intraday gain of 13.33% or $0.46. The 52-week high for the QTTB share is $53.79, that puts it down -1275.7 from that peak though still a striking 22.76% gain since the share price plummeted to a 52-week low of $3.02. The company’s market capitalization is $47.62M, and the average intraday trading volume over the past 10 days was 0.49 million shares, and the average trade volume was 312.67K shares over the past three months.

Q32 Bio Inc (QTTB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.80. QTTB has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.

Q32 Bio Inc (NASDAQ:QTTB) trade information

Q32 Bio Inc (QTTB) registered a 13.33% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 13.33% in intraday trading to $3.91, hitting a weekly high. The stock’s 5-day price performance is 9.22%, and it has moved by -84.21% in 30 days. Based on these gigs, the overall price performance for the year is -63.12%. The short interest in Q32 Bio Inc (NASDAQ:QTTB) is 1.12 million shares and it means that shorts have 2.38 day(s) to cover.

The consensus price target of analysts on Wall Street is $80, which implies an increase of 95.11% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $64 and $95 respectively. As a result, QTTB is trading at a discount of -2329.67% off the target high and -1536.83% off the low.

Q32 Bio Inc (QTTB) estimates and forecasts

Statistics show that Q32 Bio Inc has outperformed its competitors in share price, compared to the industry in which it operates. Q32 Bio Inc (QTTB) shares have gone down -79.66% during the last six months, with a year-to-date growth rate more than the industry average at 83.20% against 16.80.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -0.07%. While earnings are projected to return 25.44% in 2025, the next five years will return -9.40% per annum.

QTTB Dividends

Q32 Bio Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.